| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Frank E Jaumot is Director at BMNM, with reported holdings spanning 3 companies. Frank E Jaumot's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $5.3M at current prices.
Frank E Jaumot's largest disclosed position is in MTZ as Director, worth about $3.6M.
Frank E Jaumot has 15 Form 4 filings on record from January 2015 to July 2026, across 3 companies: Director at Nutex Health (NUTX), 2025–2026; Director at Mastec (MTZ), 2015–2016; Director at Bimini Capital Management (BMNM), 2015.
The 21 reported transactions were 10 stock awards, 6 tax withholdings, 2 option or other derivative awards and 2 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $28K and no sales.
The largest open-market purchase was 6,516 shares of BMNM at an average $2.20 on May 29, 2015, about $14K.